Experimental Leishmania (L.) amazonensis leishmaniasis: characterization and immunogenicity of subcellular fractions.
A technique developed in Trypanosoma cruzi biochemical studies was successfully used to fractionate Leishmania (Leishmania) amazonensis promastigotes. Ultrastructural analyses revealed a membrane fraction (MF) associated to subpellicular microtubules, a ribosomal-rich microsomal fraction (MicF), and a flagellar fraction (FF) free of associated membrane. All fractions proved to be immunogenic through delayed type hypersensitivity reaction assays. Therefore, a protocol was designed to test whether these fractions could elicit a protective response in mice infected by L. (L), amazonensis. The protocol consisted of a BCG injection (as cellular immunity inducer), followed by cyclophosphamide (once its cytotoxic effect is over, this immunosuppressor can increase the number of circulating leukocytes), then an injection with one of the fractions followed by a challenge. When compared to infected control animals, mice injected with any of the fractions presented a smaller footpad swelling, especially those injected with MicF or FF. Macroscopically, immunized mice under modulation by BCG presented no swelling. Histopathological studies performed on day 120 revealed fewer amastigotes and more intense inflammation in lesions of MicF and FF injected mice. Animals injected with MF presented an intermediate pattern. Parasite quantification corroborated these results. The results show that all fractions are potent immunostimulators, but MicF and FF have the strongest protective ability.
do Valle
T Zaverucha
TZ
Laboratório de Imunomodulação, Departamento de Protozoologia, Instituto Oswaldo Cruz, Fiocruz, RJ.
Gaspar
E B
EB
Souza-Lemos
C
C
Souza
C S F
CS
Márquez
F B Zamora
FB
Baetas-da-Cruz
W
W
d'Escofier
L N
LN
Côrte-Real
S
S
Calabrese
K S
KS
da Costa
S C Gonçalves
SC
D000818:Animals; D000913:Antibodies, Protozoan / Q000276:immunology; D000953:Antigens, Protozoan / Q000276:immunology*; D005260:Female; D007891:Leishmania / Q000276:immunology* / Q000472:pathogenicity; D007896:Leishmaniasis / Q000276:immunology* / Q000469:parasitology; D051379:Mice; D016052:Protozoan Vaccines / Q000276:immunology*; D013347:Subcellular Fractions / Q000276:immunology / Q000648:ultrastructure
D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D016052:Protozoan Vaccines